Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing.

Journal article

Hanson B. et al, (2021), RNA Biol, 1 - 15

Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1.

Journal article

Marsh S. et al, (2020), Mol Ther, 28, 2527 - 2539

Mutation-independent Proteomic Signatures of Pathological Progression in Murine Models of Duchenne Muscular Dystrophy.

Journal article

van Westering TLE. et al, (2020), Mol Cell Proteomics, 19, 2047 - 2068

Extracellular microRNAs exhibit sequence-dependent stability and cellular release kinetics.

Journal article

Coenen-Stass AML. et al, (2019), RNA Biol, 16, 696 - 706